Belluscura plc (AIM:BELL)
London
· Delayed Price · Currency is GBP · Price in GBX 0.6975
+0.0225 (3.33%)
Apr 25, 2025, 12:31 PM GMT+1
Belluscura Market Cap
Belluscura has a market cap or net worth of 2.71 million as of April 25, 2025. Its market cap has decreased by -77.36% in one year.
Market Cap
2.71M
Enterprise Value
2.02M
Revenue
1.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.70
Market Cap Chart
Since May 28, 2021, Belluscura's market cap has decreased from 60.02M to 2.71M, a decrease of -95.49%. That is a compound annual growth rate of -54.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 2.71M | -82.61% |
| Dec 31, 2024 | 15.58M | -50.75% |
| Dec 29, 2023 | 31.63M | -60.74% |
| Dec 30, 2022 | 80.58M | -36.80% |
| Dec 31, 2021 | 127.50M | 112.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.27B |
| GSK plc | 56.28B |
| Haleon | 33.98B |
| Smith & Nephew | 8.79B |
| ConvaTec Group | 5.28B |
| Hikma Pharmaceuticals | 4.24B |
| HUTCHMED (China) | 2.03B |
| Oxford Nanopore Technologies | 1.14B |